• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. II. Albumin in body fluids of patients with neurological disorders.

作者信息

Ghasemzadeh Nasim, Nyberg Fred, Hjertén Stellan

机构信息

Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

出版信息

J Sep Sci. 2008 Dec;31(22):3954-8. doi: 10.1002/jssc.200800386.

DOI:10.1002/jssc.200800386
PMID:19065610
Abstract

We have previously used the molecular-imprinting method for the synthesis of artificial gel antibodies, highly selective for various proteins. In the present work, we have synthesized artificial gel antibodies against human albumin with the aim to develop a simple and rapid procedure to measure the concentration of this protein in samples of clinical interest. The procedure, based on the design of a standard curve (see the preceding paper), was applied on a quantitative analysis of albumin in human plasma and cerebrospinal fluid (CSF). We found that our technique permitted detection of albumin in these body fluids with high precision and that the concentration of this protein was significantly enhanced in CSF from patients with amyotrophic lateral sclerosis (ALS), compared to control samples. This finding is in agreement with results from earlier studies, which confirms the validity of our analysis technique and suggests that the barrier permeability may be affected in ALS, perhaps also for other proteins. No enhancement in plasma levels of albumin was seen in patients with ALS, but rather a decrease. The results further indicate that our approach might also apply well to other biomarkers for the actual neurological disease and other disorders.

摘要

相似文献

1
Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. II. Albumin in body fluids of patients with neurological disorders.
J Sep Sci. 2008 Dec;31(22):3954-8. doi: 10.1002/jssc.200800386.
2
Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. I. Spectrophotometric approach to design the calibration curve for the quantification.用于临床样本中生物标志物检测和定量的高选择性人工凝胶抗体。I. 用于设计定量校准曲线的分光光度法。
J Sep Sci. 2008 Dec;31(22):3945-53. doi: 10.1002/jssc.200800385.
3
Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中血管紧张素II水平降低。
Acta Neurol Scand. 2009 May;119(5):341-4. doi: 10.1111/j.1600-0404.2008.01099.x. Epub 2008 Sep 16.
4
Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的脑脊液Flt3配体水平
Acta Neurol Scand. 2006 Sep;114(3):205-9. doi: 10.1111/j.1600-0404.2006.00704.x.
5
RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.在肌萎缩侧索硬化症患者的血清和脑脊液中,调节激活正常T细胞表达和分泌的趋化因子(RANTES)水平升高。
Amyotroph Lateral Scler. 2007 Oct;8(5):283-7. doi: 10.1080/17482960701419232.
6
Serum and cerebrospinal fluid biochemical markers of ALS.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Jun;1 Suppl 2:S61-7.
7
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease.肌萎缩侧索硬化症和帕金森病中的补体C3c及相关蛋白质生物标志物
Biochem Biophys Res Commun. 2006 Apr 21;342(4):1034-9. doi: 10.1016/j.bbrc.2006.02.051. Epub 2006 Feb 20.
8
Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury.脑脊液s100-B:重度创伤性脑损伤患者进行性颅内出血的潜在标志物。
Eur J Med Res. 2008 Nov 24;13(11):511-6.
9
The optic nerve: a new window into cerebrospinal fluid composition?视神经:了解脑脊液成分的新窗口?
Brain. 2006 Apr;129(Pt 4):1027-30. doi: 10.1093/brain/awl045. Epub 2006 Feb 27.
10
Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.优化用于研究肌萎缩侧索硬化症代谢组的脑脊液采集和储存程序。
Amyotroph Lateral Scler. 2009 Aug;10(4):229-36. doi: 10.1080/17482960902871009.

引用本文的文献

1
Lower creatinine-to-cystatin c ratio associated with increased risk of incident amyotrophic lateral sclerosis in the prospective UK biobank cohort.低肌酐/胱抑素 C 比值与前瞻性英国生物银行队列中肌萎缩侧索硬化症发病风险增加相关。
Sci Rep. 2024 Nov 16;14(1):28289. doi: 10.1038/s41598-024-79910-1.
2
Total protein is an effective loading control for cerebrospinal fluid western blots.总蛋白是脑脊液蛋白质免疫印迹法有效的上样对照。
J Neurosci Methods. 2015 Aug 15;251:72-82. doi: 10.1016/j.jneumeth.2015.05.011. Epub 2015 May 22.
3
Use of biomarkers in ALS drug development and clinical trials.
生物标志物在肌萎缩侧索硬化症药物研发及临床试验中的应用。
Brain Res. 2015 May 14;1607:94-107. doi: 10.1016/j.brainres.2014.10.031. Epub 2014 Oct 24.